logo

For the Inventor, By the Inventor

Delhi, India

Taruna Madan

This inventor holds 5 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taruna Madan. Retrieved from https://idiyas.com/inventor/taruna-madan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Dehli, IN (2005)
  • Delhi, IN (2001 - 2014)

Company Filing History:

goldMedal5 out of 2,129 
 
Council of Scientific and Industrial Research
 patents

Years Active: 2001-2014

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8883730 - Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils (2014-11-11),
2. 7381527 - Method of detection of SP-A2 gene variants (2008-06-03),
3. 7288376 - Method of detection of SP-A2 gene variants useful for prediction of predisposition to aspergillosis (2007-10-30),
4. 6902901 - Polypeptides useful for diagnosis of Aspergillus fumigatus and a process of preparing the same (2005-06-07),
5. 6262231 - Polypeptides useful for diagnosis of Aspergillus fumigatus and a process of preparing the same (2001-07-17),

Title: Taruna Madan: Innovator in Pulmonary Research

Introduction

Taruna Madan is a prominent inventor based in Delhi, India. He has made significant contributions to the field of pulmonary research, particularly in understanding and treating eosinophilic disorders. With a total of 5 patents to his name, his work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents is titled "Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic eosinophils." This invention provides a formulation using surfactant protein-D (SP-D) to modulate the activity of human eosinophils derived from hypereosinophilic patients. The utility of this invention extends to resolving eosinophilic inflammations in diseases such as neuromuscular and respiratory disorders, hypereosinophilic leukemias, and various skin diseases.

Another notable patent is the "Method of detection of SP-A2 gene variants." This invention offers a method for predicting an individual's susceptibility to pulmonary tuberculosis. It involves amplifying genomic DNA from patients and normal individuals, sequencing the amplified product, and identifying sequence variations by comparing them with the existing sequence of the human SP-A2 gene.

Career Highlights

Taruna Madan is affiliated with the Council of Scientific and Industrial Research, where he conducts his research and develops innovative solutions for complex medical challenges. His work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.

Collaborations

He collaborates with esteemed colleagues, including Puranam Usha Sarma and Shweta Saxena, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Taruna Madan's contributions to pulmonary research through his patents and collaborations highlight his dedication to addressing critical health issues. His innovative work continues to pave the way for advancements in the treatment of eosinophilic disorders and pulmonary diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…